{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:29:42Z","timestamp":1788834582379,"version":"build-2803163510"},"reference-count":220,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inherited muscular diseases (MDs) are genetic degenerative disorders typically caused by mutations in a single gene that affect striated muscle and result in progressive weakness and wasting in affected individuals. Cardiac muscle can also be involved with some variability that depends on the genetic basis of the MD (Muscular Dystrophy) phenotype. Heart involvement can manifest with two main clinical pictures: left ventricular systolic dysfunction with evolution towards dilated cardiomyopathy and refractory heart failure, or the presence of conduction system defects and serious life-threatening ventricular arrhythmias. The two pictures can coexist. In these cases, heart transplantation (HTx) is considered the most appropriate option in patients who are not responders to the optimized standard therapeutic protocols. However, cardiac transplant is still considered a relative contraindication in patients with inherited muscle disorders and end-stage cardiomyopathies. High operative risk related to muscle impairment and potential graft involvement secondary to the underlying myopathy have been the two main reasons implicated in the generalized reluctance to consider cardiac transplant as a viable option. We report an overview of cardiac involvement in MDs and its possible association with the underlying molecular defect, as well as a systematic review of HTx outcomes in patients with MD-related end-stage dilated cardiomyopathy, published so far in the literature.<\/jats:p>","DOI":"10.3390\/ijms25105289","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:03:08Z","timestamp":1715673788000},"page":"5289","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0925-7158","authenticated-orcid":false,"given":"Luisa","family":"Politano","sequence":"first","affiliation":[{"name":"Cardiomyology and Medical Genetics, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"ref_3","unstructured":"Nigro, G., Comi, L.I., Politano, L., and Nigro, G. (2004). Engel & Franzini-Armstrong: Myology, McGRAW-HILL. Chapter 45."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/mus.26014","article-title":"Cardiac involvement in the muscular dystrophies","volume":"57","author":"Silvestri","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_5","first-page":"128","article-title":"Management of cardiac involvement in muscular dystrophies: Pediatric versus adult forms","volume":"35","author":"Palladino","year":"2016","journal-title":"Acta Myol."},{"key":"ref_6","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: Retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2304","DOI":"10.1212\/WNL.0000000000012910","article-title":"Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis","volume":"97","author":"Broomfield","year":"2021","journal-title":"Neurology"},{"key":"ref_8","first-page":"477","article-title":"Survival of patients with Duchenne muscular dystrophy","volume":"89","author":"Solis","year":"2018","journal-title":"Rev. Chil. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000511962","article-title":"New Insights in Adherence and Survival in Myotonic Dystrophy Patients Using Home Mechanical Ventilation","volume":"100","author":"Seijger","year":"2021","journal-title":"Respiration"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"00176","DOI":"10.1183\/23120541.00176-2023","article-title":"Cardiomyopathy as cause of death in Duchenne muscular dystrophy: A longitudinal observational study","volume":"9","author":"Lechner","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e014004","DOI":"10.1161\/JAHA.119.014004","article-title":"Cardiac intervention improves heart disease and clinical outcomes in patients with muscular dystrophy in a multidisciplinary care setting","volume":"9","author":"Nikhanj","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2016.09.019","article-title":"Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review","volume":"27","author":"Rodrigues","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e005872","DOI":"10.1161\/CIRCHEARTFAILURE.119.005872","article-title":"Keeping an Open Mind: Heart Transplant in Patients with Muscular Dystrophy","volume":"13","author":"Moayedi","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/WCO.0000000000000739","article-title":"Update in Duchenne and Becker muscular dystrophy","volume":"32","author":"Waldrop","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_16","first-page":"179","article-title":"Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies","volume":"39","author":"Hoffman","year":"2020","journal-title":"Acta Myol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","article-title":"X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus","volume":"87","author":"Towbin","year":"1993","journal-title":"Circulation"},{"key":"ref_18","first-page":"984","article-title":"Genetic analysis of the Duchenne muscular dystrophy gene","volume":"115","author":"Prior","year":"1991","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Viggiano, E., Picillo, E., Passamano, L., Onore, M.E., Piluso, G., Scutifero, M., Torella, A., Nigro, V., and Politano, L. (2023). Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy. Genes, 14.","DOI":"10.3390\/genes14010214"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.880180304","article-title":"Evaluation of the cardiomyopathy in Becker muscular dystrophy","volume":"18","author":"Nigro","year":"1995","journal-title":"Muscle Nerve"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.nmd.2010.04.008","article-title":"Hereditary muscular dystrophies and the heart","volume":"20","author":"Hermans","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review","volume":"72","author":"Arbustini","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","article-title":"Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies","volume":"275","author":"Politano","year":"1996","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Sheri, N., Nguyen, Q., and Yokota, T. (2020). Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies. Genes, 11.","DOI":"10.3390\/genes11070765"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nmd.2023.01.003","article-title":"263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: Refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13\u201315 May 2022","volume":"33","author":"Sarkozy","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10741-009-9156-8","article-title":"Cardiomyopathy in Duchenne muscular dystrophy: Pathogenesis and therapeutics","volume":"15","author":"Fayssoil","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"ref_29","first-page":"CD003725","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"2016","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9149(02)03429-X","article-title":"Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy","volume":"91","author":"Silversides","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_33","first-page":"24","article-title":"Treatment of dystrophinopathic cardiomyopathy: Review of the literature and personal results","volume":"31","author":"Politano","year":"2012","journal-title":"Acta Myol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/21678707.2016.1234373","article-title":"Managing dystrophinopathic cardiomyopathy","volume":"4","author":"Politano","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","article-title":"Management of Cardiac Involvement Associated with Neuromuscular Diseases: A Scientific Statement From the American Heart Association","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1542\/peds.2018-0333I","article-title":"Cardiac Management of the Patient with Duchenne Muscular Dystrophy","volume":"142","author":"Buddhe","year":"2018","journal-title":"Pediatrics"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Meyers, T.A., and Townsend, D. (2019). Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174098"},{"key":"ref_38","first-page":"1202","article-title":"Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"11","author":"Nguyen","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/14737175.2023.2249607","article-title":"Gene therapy for Duchenne muscular dystrophy: An update on the latest clinical developments","volume":"23","author":"Mbakam","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jnnp.29.4.338","article-title":"Unusual type of benign x-linked muscular dystrophy","volume":"29","author":"Emery","year":"1966","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ng1294-323","article-title":"Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy","volume":"8","author":"Bione","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/hmg\/4.10.2003","article-title":"SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: Definition of a small C-terminal region required for emerin function","volume":"4","author":"Nigro","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0960-8966(98)00097-2","article-title":"Emerin and cardiomyopathy in Emery\u2013Dreifuss muscular dystrophy","volume":"9","author":"Funakoshi","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1242\/jcs.114.24.4447","article-title":"Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy","volume":"114","author":"Raharjo","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/heartjnl-2017-312338","article-title":"Lamin and the heart","volume":"104","author":"Captur","year":"2017","journal-title":"Heart"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: Young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/19491034.2018.1462635","article-title":"Clinical aspects of Emery-Dreifuss muscular dystrophy","volume":"9","year":"2018","journal-title":"Nucleus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13023-019-1245-8","article-title":"Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset","volume":"14","author":"Ditaranto","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_51","first-page":"33","article-title":"Cardiac diseases as a predictor warning of hereditary muscle diseases. The case of laminopathies","volume":"38","author":"Petillo","year":"2019","journal-title":"Acta Myol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1536\/ihj.17-604","article-title":"Cardiac Involvement in Emery-Dreifuss Muscular Dystrophy and Related Management Strategies","volume":"60","author":"Wang","year":"2019","journal-title":"Int. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5603\/CJ.2020.0021","article-title":"Dilated cardiomyopathy with severe arrhythmias in Emery-Dreifuss muscular dystrophy","volume":"27","author":"Majewski","year":"2020","journal-title":"Cardiol. J."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Marchel, M., Madej-Pilarczyk, A., Tymi\u0144ska, A., Steckiewicz, R., Ostrowska, E., Wysi\u0144ska, J., Russo, V., Grabowski, M., and Opolski, G. (2021). Cardiac Arrhythmias in Muscular Dystrophies Associated with Emerinopathy and Laminopathy: A Cohort Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040732"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/europace\/eum236","article-title":"\u2018Unexpected\u2019 sudden death avoided by implantable cardioverter defibrillator in Emery Dreifuss patient","volume":"9","author":"Golzio","year":"2007","journal-title":"Europace"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nmd.2009.12.004","article-title":"Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery\u2013Dreifuss muscular dystrophy","volume":"20","author":"Nigro","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijcard.2015.10.176","article-title":"Sudden cardiac death in neuromuscular disorders","volume":"203","author":"Finsterer","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M18-2768","article-title":"Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy","volume":"171","author":"Peretto","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_59","first-page":"216","article-title":"Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry","volume":"74","author":"Ochoa","year":"2021","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_60","first-page":"207","article-title":"LGMD. Identification, description, and classification","volume":"39","author":"Angelini","year":"2020","journal-title":"Acta Myol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1002\/jcp.27907","article-title":"Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: A review","volume":"234","author":"Taghizadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/brain\/77.2.169","article-title":"On the classification, natural history and treatment of the myopathies","volume":"77","author":"Walton","year":"1954","journal-title":"Brain"},{"key":"ref_63","first-page":"1835","article-title":"An unknown type of muscular dystrophy. I. Analysis of two cases reports","volume":"65","author":"Rideau","year":"1989","journal-title":"Sem. Hop. Paris"},{"key":"ref_64","first-page":"1901","article-title":"An unknown type of muscular dystrophy. II. Autosomal recessive inheritance","volume":"31","author":"Rideau","year":"1989","journal-title":"Sem. Hop. Paris"},{"key":"ref_65","first-page":"1343","article-title":"Une forme m\u00e9connue de myopathie. III. Definition et caract\u00e8res cliniques","volume":"67","author":"Rideau","year":"1991","journal-title":"Sem. Hop. Paris"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0960-8966(99)00064-4","article-title":"66th\/67th ENMC sponsored international workshop: The limb-girdle muscular dystrophies, 26-28 March 1999, Naarden, The Netherlands","volume":"9","author":"Beckmann","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"ref_67","first-page":"1","article-title":"Genetic basis of limb-girdle muscular dystrophies: The 2014 update","volume":"33","author":"Nigro","year":"2014","journal-title":"Acta Myol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.0000000000002800","article-title":"The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients","volume":"87","author":"Savarese","year":"2016","journal-title":"Neurology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: Limb girdle muscular dystrophies\u2014Nomenclature and reformed classification","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ana.20283","article-title":"Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I","volume":"56","author":"Poppe","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.nmd.2005.02.004","article-title":"Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation","volume":"15","author":"Krasnianski","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00415-006-0213-0","article-title":"Cardiac involvement in limb-girdle muscular dystrophy 2I: Conventional cardiac diagnostic and cardiovascular magnetic resonance","volume":"253","author":"Gaul","year":"2006","journal-title":"J. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2008-1081465","article-title":"Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations","volume":"39","author":"Kefi","year":"2008","journal-title":"Neuropediatrics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nmd.2008.06.365","article-title":"Cardiac assessment of limb\u2013girdle muscular dystrophy 2I patients: An echography, Holter ECG and magnetic resonance imaging study","volume":"18","author":"Wahbi","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/jnnp.2007.141804","article-title":"Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients","volume":"80","author":"Bourteel","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/mus.27052","article-title":"Cardiomyopathy in limb girdle muscular dystrophy R9, FKRP related","volume":"62","author":"Libell","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.37.2.102","article-title":"Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations","volume":"37","author":"Barresi","year":"2000","journal-title":"J. Med. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0960-8966(00)00174-7","article-title":"Evaluation of cardiac and respiratory involvement in sarcoglycanopathies","volume":"11","author":"Politano","year":"2001","journal-title":"Neuromuscul. Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0960-8966(02)00280-8","article-title":"LGMD2E patients risk developing dilated cardiomyopathy","volume":"13","author":"Fanin","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2008.12.048","article-title":"Cardiac diseases in sarcoglycanopathies","volume":"144","author":"Fayssoil","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-013-0276-5","article-title":"Left ventricular function in alpha-sarcoglycanopathy and gamma-sarcoglycanopathy","volume":"114","author":"Fayssoil","year":"2014","journal-title":"Acta Neurol. Belg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.24233","article-title":"Cardiac involvement in Dutch patients with sarcoglycanopathy: A cross-sectional cohort and follow-up study","volume":"50","author":"Dekker","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Fayssoil, A., Ogna, A., Chaffaut, C., Chevret, S., Guimar\u00e3es-Costa, R., Leturcq, F., Wahbi, K., Prigent, H., Lofaso, F., and Nardi, O. (2016). Natural History of Cardiac and Respiratory Involvement, Prognosis and Predictive Factors for Long-Term Survival in Adult Patients with Limb Girdle Muscular Dystrophies Type 2C and 2D. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153095"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.25192","article-title":"The Italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis","volume":"55","author":"Magri","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/brain\/awaa228","article-title":"New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy","volume":"143","author":"Bello","year":"2020","journal-title":"Brain"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ene.14592","article-title":"Clinical correlations and long-term follow-up in 100 patients with sarcoglycanopathies","volume":"28","author":"Wahbi","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s11845-021-02855-1","article-title":"Genotype\u2013phenotype correlations in alpha-sarcoglycanopathy: A systematic review","volume":"191","author":"Carson","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.20973","article-title":"Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness","volume":"60","author":"Murakami","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_89","first-page":"132","article-title":"Homozygous Fukutin Missense Mutation in Two Mexican Siblings with Dilated Cardiomyopathy","volume":"73","author":"Avila","year":"2020","journal-title":"Rev. Investig. Clin."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Gaertner, A., Burr, L., Klauke, B., Brodehl, A., Laser, K.T., Klingel, K., Tiesmeier, J., Schulz, U., zu Knyphausen, E., and Gummert, J. (2022). Compound Heterozygous FKTN Variants in a Patient with Dilated Cardiomyopathy Led to an Aberrant \u03b1-Dystroglycan Pattern. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126685"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2005.10.008","article-title":"Genotype\u2013phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin","volume":"88","author":"Bos","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/acn3.51172","article-title":"LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort","volume":"7","author":"Zambon","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF01671719","article-title":"\u00dcber das klinische und anatomische Bild des Muskelschwunds der Myotoniker","volume":"37","author":"Steinert","year":"1909","journal-title":"Nervenheilkd"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol. Clin."},{"key":"ref_95","first-page":"1682","article-title":"Myotonic Muscular Dystrophies","volume":"25","author":"Johnson","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1023\/A:1005388218625","article-title":"Trinucleotide repeat disorders","volume":"20","author":"Harper","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"001","DOI":"10.1097\/CRD.0b013e31821950f9","article-title":"Myotonic dystrophies and the heart","volume":"20","author":"Chaudhry","year":"2012","journal-title":"Cardiol. Rev."},{"key":"ref_98","first-page":"110","article-title":"The heart and cardiac pacing in Steinert disease","volume":"31","author":"Nigro","year":"2012","journal-title":"Acta Myol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ijcard.2015.03.069","article-title":"Myotonic dystrophy and the heart: A systematic review of evaluation and management","volume":"184","author":"Lau","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.acvd.2013.08.003","article-title":"Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1","volume":"106","author":"Wahbi","year":"2013","journal-title":"Arch Cardiovasc Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e014006","DOI":"10.1161\/JAHA.119.014006","article-title":"Clinical Care Recommendations for Cardiologists Treating Adults with Myotonic Dystrophy","volume":"9","author":"McNally","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cardfail.2019.07.548","article-title":"Prevalence of Left Ventricular Systolic Dysfunction in Myotonic Dystrophy Type 1: A Systematic Review","volume":"26","author":"Russo","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-08-045031-5.00011-6","article-title":"Myofibrillar myopathies","volume":"101","author":"Selcen","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/B978-0-444-59565-2.00005-8","article-title":"Myofibrillar myopathies","volume":"113","author":"Claeys","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Maggi, L., Mavroidis, M., Psarras, S., Capetanaki, Y., and Lattanzi, G. (2021). Skeletal and Cardiac Muscle Disorders Caused by Mutations in Genes Encoding Intermediate Filament Proteins. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084256"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s13353-018-0463-4","article-title":"Myofibrillar myopathy in the genomic context","volume":"59","author":"Fichna","year":"2018","journal-title":"J. Appl. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12551-018-0429-0","article-title":"Molecular insights into cardiomyopathies associated with desmin (DES) mutations","volume":"10","author":"Brodehl","year":"2018","journal-title":"Biophys. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/brain\/awh033","article-title":"Desmin myopathy","volume":"127","author":"Goldfarb","year":"2004","journal-title":"Brain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-012-1057-6","article-title":"Desminopathies: Pathology and mechanisms","volume":"125","author":"Clemen","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12551-018-0443-2","article-title":"Intermediate filaments in cardiomyopathy","volume":"10","author":"Tsikitis","year":"2018","journal-title":"Biophys. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM200003163421104","article-title":"desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene","volume":"342","author":"Dalakas","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"H1220","DOI":"10.1152\/ajpheart.00601.2011","article-title":"Desmin-related cardiomyopathy: An unfolding story","volume":"301","author":"McLendon","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.ejhg.5201980","article-title":"Myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7: Corroboration and narrowing of the critical region on 10q22.3","volume":"16","author":"Kuhl","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.amjcard.2012.10.017","article-title":"Desmin mutations and arrhythmogenic right ventricular cardiomyopathy","volume":"111","author":"Lorenzon","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Onore, M.E., Savarese, M., Picillo, E., Passamano, L., Nigro, V., and Politano, L. (2022). Bi-Allelic DES Gene Variants Causing Autosomal Recessive Myofibrillar Myopathies Affecting Both Skeletal Muscles and Cardiac Function. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415906"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/acn3.287","article-title":"Natural history of LGMD2A for delineating outcome measures in clinical trials","volume":"3","author":"Richard","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/brain\/awq294","article-title":"A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy","volume":"134","author":"Hicks","year":"2011","journal-title":"Brain"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/acn3.50801","article-title":"Clinical and molecular findings in a cohort of ANO5-related myopathy","volume":"6","author":"Silva","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0960-8966(03)00100-7","article-title":"The 10 autosomal recessive limb-girdle muscular dystrophies","volume":"13","author":"Zatz","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/jnnp-2017-317488","article-title":"Muscle MRI in patients with dysferli-nopathy: Pattern recognition and implications for clinical trials","volume":"89","author":"LLauger","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/acn3.51042","article-title":"Global FKRP Registry: Observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9","volume":"7","author":"Murphy","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nmd.2022.11.005","article-title":"Epidemiology and natural history in 101 subjects with FKRP-related limb-girdle muscular dystrophy R9. The Norwegian LGMDR9 cohort study (2020)","volume":"33","author":"Jensen","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/323646a0","article-title":"Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene","volume":"323","author":"Monaco","year":"1986","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/jbio:2005001","article-title":"Bases mol\u00e9culaires des dystrophinopathies [Molecular bases of dystrophinopathies]","volume":"199","author":"Leturcq","year":"2005","journal-title":"J. Soc. Biol."},{"key":"ref_125","first-page":"239","article-title":"Genotype-phenotype correlation in patients with deletions of Duchenne\/Becker gene","volume":"2","author":"Politano","year":"1991","journal-title":"Acta Cardiomyol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0960-8966(94)90073-6","article-title":"Mutation of dystrophin gene and cardiomyopathy","volume":"4","author":"Nigro","year":"1994","journal-title":"Neuromuscul. Disord."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/0735-1097(93)90781-U","article-title":"Cardiac involvement in Becker muscular dystrophy","volume":"22","author":"Melacini","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCGENETICS.109.867242","article-title":"Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy","volume":"2","author":"Kaspar","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/mt.2008.264","article-title":"Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged mdx mice","volume":"17","author":"Bostick","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ejhf.2250","article-title":"Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy","volume":"23","author":"Wahbi","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.108.172197","article-title":"Emerin and the nuclear lamina in muscle and cardiac disease","volume":"103","author":"Holaska","year":"2008","journal-title":"Circ. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","article-title":"Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy","volume":"156","author":"Parks","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00395-008-0748-6","article-title":"Identification of mutational hot spots in LMNA encoding lamin A\/C in patients with familial dilated cardiomyopathy","volume":"104","author":"Perrot","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and non-arrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardfail.2013.03.001","article-title":"Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy","volume":"19","author":"Brodt","year":"2013","journal-title":"J. Card. Fail."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e000474","DOI":"10.1136\/openhrt-2016-000474","article-title":"Clinical disease presentation and ECG characteristics of LMNA mutation carriers","volume":"4","author":"Ollila","year":"2017","journal-title":"Open Heart"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5603\/CJ.a2014.0037","article-title":"Lamin A\/C mutations in dilated cardiomyopathy","volume":"21","author":"Tesson","year":"2014","journal-title":"Cardiol. J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1042\/BST20110670","article-title":"Clinical and genetic heterogeneity in laminopathies","volume":"39","author":"Bertrand","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/01.wnl.0000261254.87181.80","article-title":"Phenotypic clustering of lamin A\/C mutations in neuromuscular patients","volume":"69","author":"Benedetti","year":"2007","journal-title":"Neurology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.0000000000000934","article-title":"LMNA -associated myopathies: The Italian experience in a large cohort of patients","volume":"83","author":"Maggi","year":"2014","journal-title":"Neurology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/humu.20652","article-title":"The Human Intermediate Filament Database: Comprehensive information on a gene family involved in many human diseases","volume":"29","author":"Szeverenyi","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: Do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"Bonne","year":"2005","journal-title":"J. Mol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1242\/jcs.00599","article-title":"Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo","volume":"116","author":"Holt","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yjmcc.2007.11.008","article-title":"Lamin A\/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease","volume":"44","author":"Wolf","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.52.1.176","article-title":"The clinical spectrum of sarcoglycanopathies","volume":"52","author":"Angelini","year":"1999","journal-title":"Neurology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/brain\/awab301","article-title":"Clinical and genetic spectrum of a large cohort of patients with \u03b4-sarcoglycan muscular dystrophy","volume":"145","author":"Bruno","year":"2022","journal-title":"Brain"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Kang, P.B., Feener, C.A., Estrella, E., Thorne, M., White, A.J., Darras, B.T., Amato, A.A., and Kunkel, L.M. (2007). LGMD2I in a North American population. BMC Musculoskelet. Disord., 8.","DOI":"10.1186\/1471-2474-8-115"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ana.20824","article-title":"High prevalence and phenotype\u2013genotype correlations of limb girdle muscular dystrophy type 2I in Denmark","volume":"59","author":"Sveen","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1001\/jama.1993.03500150072029","article-title":"Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring","volume":"269","author":"Redman","year":"1993","journal-title":"JAMA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0735-1097(94)00351-P","article-title":"Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy","volume":"25","author":"Melacini","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1034\/j.1399-0004.2001.590509.x","article-title":"Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy","volume":"59","author":"Finsterer","year":"2001","journal-title":"Clin. Genet."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e001526","DOI":"10.1161\/CIRCGENETICS.116.001526","article-title":"Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry","volume":"10","author":"Wahbi","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s10072-018-3530-z","article-title":"Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1","volume":"39","author":"Park","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI38027","article-title":"Tragedy in a heartbeat: Malfunctioning desmin causes skeletal and cardiac muscle disease","volume":"119","author":"Goldfarb","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ejhg.2012.39","article-title":"Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation","volume":"20","author":"Hedberg","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-0004.2010.01512.x","article-title":"Desmin-related myopathy","volume":"80","author":"Jongbloed","year":"2011","journal-title":"Clin. Genet."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CM9.0000000000000001","article-title":"A novel phenotype with splicing mutation identified in a Chinese family with desminopathy","volume":"132","author":"Fan","year":"2019","journal-title":"Chin. Med. J. (Engl.)"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"McLaughlin, H.M., Kelly, M.A., Hawley, P.P., Darras, B.T., Funke, B., and Picker, J. (2013). Compound heterozygosity of predicted loss-of-function DES variants in a family with recessive des-minopathy. BMC Med. Genet., 14.","DOI":"10.1186\/1471-2350-14-68"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","article-title":"Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene","volume":"6","author":"Asimaki","year":"2009","journal-title":"Heart Rhythm."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12471-011-0233-y","article-title":"Recurrent and founder mutations in the Netherlands: The cardiac phenotype of DES founder mutations p.S13F and p.N342D","volume":"20","author":"Ippel","year":"2012","journal-title":"Neth. Heart J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1093\/hmg\/ddq387","article-title":"De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy","volume":"19","author":"Klauke","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/CIRCULATIONAHA.117.028719","article-title":"Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy\/Dysplasia","volume":"137","author":"Carriel","year":"2018","journal-title":"Circulation"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2020.12.050","article-title":"Functional characterization of novel alpha-helical rod domain desmin (DES) pathogenic variants associated with dilated cardiomyopathy, atrioventricular block and a risk for sudden cardiac death","volume":"329","author":"Fischer","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e002149","DOI":"10.1161\/JAHA.115.002149","article-title":"Arrhythmogenic phenotype in dilated cardiomyopathy: Natural history and predictors of life-threatening arrhythmias","volume":"4","author":"Spezzacatene","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/CIRCULATIONAHA.118.033558","article-title":"Arrhythmogenic Cardiomyopathy: Mechanotransduction Going Wrong","volume":"137","author":"Mestroni","year":"2018","journal-title":"Circulation"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cjca.2020.11.017","article-title":"The Novel Desmin Variant p.Leu115Ile Is Associated with a Unique Form of Biventricular Arrhythmogenic Cardiomyopathy","volume":"37","author":"Protonotarios","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"ref_167","first-page":"804","article-title":"Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy","volume":"12","author":"Rees","year":"1993","journal-title":"J. Heart Lung Transplant."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.healun.2009.08.030","article-title":"Clinical outcomes after cardiac transplantation in muscular dystrophy patients","volume":"29","author":"Wu","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e005447","DOI":"10.1161\/CIRCHEARTFAILURE.118.005447","article-title":"Heart transplantation in muscular dystrophy patients. Is it a viable option?","volume":"13","author":"Wells","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nmd.2011.06.774","article-title":"P1.14 Cardiac transplantation in Duchenne muscular dystrophy: A case report","volume":"21","author":"Cripe","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/ehf2.12905","article-title":"Is heart transplantation a real option in patients with Duchenne syndrome? Inferences from a case report","volume":"7","author":"Piperata","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_172","first-page":"753","article-title":"Dilated cardiomyopathy and successful cardiac transplantation in Becker\u2019s muscular distrophy. Follow-up after two years","volume":"18","author":"Casazza","year":"1988","journal-title":"G. Ital. Cardiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.1989.00520420127038","article-title":"Cardiac transplantation in a patient with muscular dystrophy and cardiomyopathy","volume":"46","author":"Donofrio","year":"1989","journal-title":"Arch. Neurol."},{"key":"ref_174","first-page":"952","article-title":"[Cardiomyopathy in Becker muscular dystrophy]","volume":"30","author":"Sakata","year":"1990","journal-title":"Rinsho Shinkeigaku"},{"key":"ref_175","first-page":"1451","article-title":"Heart transplantation in patients with \u201cso-called\u201d contraindications","volume":"22","author":"Anthuber","year":"1990","journal-title":"Transplant. Proc."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0960-8966(94)90006-X","article-title":"Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy","volume":"4","author":"Piccolo","year":"1994","journal-title":"Neuromuscul. Disord."},{"key":"ref_177","first-page":"969","article-title":"Troponin I as a specific marker for heart damage after heart transplantation in a patient with Becker type muscular dystrophy","volume":"16","author":"Fiocchi","year":"1997","journal-title":"J. Heart Lung Transplant."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0960-8966(99)00045-0","article-title":"Cardiac involvement in Becker\u2019s muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement","volume":"9","author":"Finsterer","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0041-1345(00)02607-5","article-title":"Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: Molecular and biochemical defects on cardiac and skeletal muscle","volume":"33","author":"Melacini","year":"2001","journal-title":"Transplant. Proc."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1053-2498(01)00393-X","article-title":"Successful bridge to transplantation in a patient with Becker muscular dystrophy\u2013associated cardiomyopathy","volume":"21","author":"Leprince","year":"2002","journal-title":"J. Heart Lung Transplant."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0041-1345(03)00515-3","article-title":"Successful heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy","volume":"35","author":"Delgado","year":"2003","journal-title":"Transplant. Proc."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.apmr.2005.03.036","article-title":"Cardiac rehabilitation after heart transplantation in a patient with becker\u2019s muscular dystrophy: A case report","volume":"86","author":"Srinivasan","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_183","first-page":"E604-6","article-title":"Becker\u2019s muscular dystrophy and orthotopic heart transplantation: Perioperative considerations","volume":"9","author":"Komanapalli","year":"2006","journal-title":"Heart Surg. Forum."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejcts.2005.11.012","article-title":"Successful heart transplantation in Becker\u2019s muscular dystrophy","volume":"29","author":"Zingarelli","year":"2006","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/0883073810367683","article-title":"End-stage cardiac disease as an initial presentation of systemic myopathies: Case series and literature review","volume":"25","author":"Katzberg","year":"2010","journal-title":"J. Child Neurol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/eurheartj\/ehq193","article-title":"Unusual right heart failure in a patient with heart transplant","volume":"31","author":"Fournier","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5582\/irdr.2017.01024","article-title":"Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series","volume":"6","author":"Papa","year":"2017","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10353-013-0195-y","article-title":"Cardiac manifestation in muscular dystrophies leading to heart transplantation","volume":"45","author":"Steger","year":"2013","journal-title":"Eur. Surg."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0960-8966(97)87239-2","article-title":"Myopathy\/rhabdomyolisis in patients after heart transplantation by presurgical treatment with lipid-lowering drugs? Interaction of cyclosporine and HMG-CoA reductase inhibitor therapy?","volume":"7","author":"Ketelsen","year":"1997","journal-title":"Neuromuscul. Disord."},{"key":"ref_190","first-page":"534","article-title":"Rapidly manifested heart failure treated with left ventricle assist device and heart transplantation in patient with Becker muscular dystrophy. In Abstracts of the Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, Paris, France, 29 April\u20132 May 2017","volume":"19","author":"Bajoras","year":"2017","journal-title":"Eur. J. Heart Fail"},{"key":"ref_191","first-page":"584","article-title":"Is Becker Dystrophinopathy a Contraindication to Heart Transplant? Experience in a Single Institution","volume":"72","year":"2019","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e14645","DOI":"10.1111\/ctr.14645","article-title":"Heart transplantation in muscular dystrophy: Single-center analysis","volume":"36","author":"Visrodia","year":"2022","journal-title":"Clin. Transplant."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0960-8966(98)00071-6","article-title":"Cardiac transplantation in a Duchenne muscular dystrophy carrier","volume":"8","author":"Melacini","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1053-2498(00)00240-0","article-title":"Cardiomyopathy in a carrier of Duchenne\u2019s muscular dystrophy","volume":"20","author":"Davies","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1053\/j.jvca.2021.09.047","article-title":"Orthotopic Heart Transplantation in Manifesting Carrier of Duchenne Muscular Dystrophy","volume":"36","author":"Cullom","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00314751","article-title":"Cardiac transplantation in female Emery-Dreifuss muscular dystrophy","volume":"237","author":"Merchut","year":"1990","journal-title":"J. Neurol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1053-2498(03)00204-3","article-title":"Cardiac transplantation in twins with autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"23","author":"Hallowell","year":"2004","journal-title":"J. Heart Lung Transplant."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0035-3787(05)84972-0","article-title":"Autosomal dominant limb-girdle muscular dystrophy associated with conduction defects (LGMD1B): A description of 8 new families with the LMNA gene mutations]","volume":"161","author":"Demay","year":"2005","journal-title":"Rev. Neurol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/hrt.2004.056721","article-title":"Novel mutations in the lamin A\/C gene in heart transplant recipients with end stage dilated cardiomyopathy","volume":"92","author":"Karkkainen","year":"2006","journal-title":"Heart"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1055\/s-2007-985632","article-title":"Kardiologische Befunde bei Hauptmann-Thannhauser-Muskeldystrophie (autosomal dominante Emery-Dreifuss-Muskeldystrophie) [Cardiologic findings in Hauptmann-Thannhauser muscular dystrophy (autosomal dominant Emery-Dreifuss muscular dystrophy)]","volume":"132","author":"Cuneo","year":"2007","journal-title":"DMW\u2014Dtsch. Med. Wochenschr."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1016\/j.transproceed.2007.06.076","article-title":"Heart transplantation in patients with emery-dreifuss muscular dystrophy: Case reports","volume":"39","author":"Botta","year":"2007","journal-title":"Transplant. Proc."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.ijcard.2009.04.036","article-title":"Heart transplantation in 7 patients from a single family with limb-girdle muscular dystrophy caused by lamin A\/C mutation","volume":"137","author":"Ambrosi","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nmd.2010.03.016","article-title":"Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication","volume":"20","author":"Volpi","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.4022\/jafib.1468","article-title":"Dilated cardiomyopathy with severe arrhythmias in Emery-Dreifuss muscular dystrophy: From ablation to heart transplantation","volume":"9","author":"Blagova","year":"2016","journal-title":"J. Atr. Fibrillation"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.redar.2022.11.006","article-title":"Heart transplant anesthetic approach in a patient with Emery Dreyfuss muscular dystrophy: A case report","volume":"70","author":"Martins","year":"2023","journal-title":"Rev. Esp. Anestesiol. Reanim. (Engl. Ed.)"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e20220560","DOI":"10.36660\/abc.20220560","article-title":"Cardiac Rehabilitation in a Transplanted Person with Emery-Dreifuss Muscular Dystrophy","volume":"120","author":"Loureiro","year":"2023","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.79.4.412","article-title":"Radiofrequency catheter ablation for atrial flutter following orthotopic heart transplantation","volume":"79","author":"Pitt","year":"1998","journal-title":"Heart"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nmd.2007.09.013","article-title":"Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy","volume":"18","author":"Petrini","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/mus.21432","article-title":"Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I","volume":"40","author":"Margeta","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"e29180","DOI":"10.1097\/MD.0000000000029180","article-title":"Early cardiac rehabilitation after heart transplantation in a patient with limb-girdle muscular dystrophy: A case report","volume":"101","author":"Kim","year":"2022","journal-title":"Medicine"},{"key":"ref_211","first-page":"604","article-title":"Aortic valve replacement thirty-one months after orthotopic heart transplantation","volume":"10","author":"Goenen","year":"1991","journal-title":"J. Heart Lung Transplant."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/apmr.2002.29619","article-title":"Importance of physical rehabilitation before and after cardiac transplantation in a patient with myotonic dystrophy: A case report","volume":"83","author":"Conraads","year":"2002","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_213","first-page":"267","article-title":"Heart transplantation in a patient with Myotonic Dystrophy type 1 and end-stage dilated cardiomyopathy: A short term follow-up","volume":"37","author":"Papa","year":"2018","journal-title":"Acta Myol."},{"key":"ref_214","first-page":"1723","article-title":"Clinical and histologic studies of a Qatari family with myofibrillar myopathy","volume":"25","author":"Gehani","year":"2004","journal-title":"Saudi Med. J."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"E1150","DOI":"10.1212\/WNL.0000000000012542","article-title":"Expanding Spectrum of Desmin-Related Myopathy, Long-term Follow-up, and Cardiac Transplantation","volume":"97","author":"Shelly","year":"2021","journal-title":"Neurology"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM199509143331114","article-title":"Serum antibodies to the deleted dystrophin sequence after cardiac transplantation in a patient with Becker\u2019s muscular dystrophy","volume":"333","author":"Bittner","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(10)70196-4","article-title":"Treatment of Duchenne muscular dystrophy with ciclosporin A: A randomised, double-blind, placebo-controlled multicentre trial","volume":"9","author":"Kirschner","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/dmcn.15525","article-title":"Females with dystrophinopathy: A neglected patient population","volume":"65","author":"Politano","year":"2023","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1253\/circj.CJ-18-1060","article-title":"Heart Transplantation Ameliorates Ambulation Capacity in Patients with Muscular Dystrophy\u2014An Analysis of 9 Cases","volume":"83","author":"Seguchi","year":"2019","journal-title":"Circ. J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mayocp.2015.12.002","article-title":"Association between early cardiac rehabilitation and long-term survival in cardiac transplant recipients","volume":"91","author":"Rosenbaum","year":"2016","journal-title":"Mayo Clin. Proc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/10\/5289\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:20Z","timestamp":1760107280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/10\/5289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":220,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijms25105289"],"URL":"https:\/\/doi.org\/10.3390\/ijms25105289","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]}}}